Mortality by stage for right- versus left-sided colon cancer: Analysis of surveillance, epidemiology, and end results-medicare data

Journal of Clinical Oncology

Volumn 29, Issue 33, 2011, Pages 4401-4409

  Weiss, Jennifer M ^a   Pfau, Patrick R ^a   O'Connor, Erin S ^a   King, Jonathan ^a   LoConte, Noelle ^a,b   Kennedy, Gregory ^a   Smith, Maureen A ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PREDICTOR VARIABLE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MEDICARE; NEOPLASM STAGING; SEER PROGRAM; UNITED STATES;

EID: 81755172143     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.36.4414     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2009. CA Cancer J Clin 59:225-249, 2009
2. Edwards BK, Ward E, Kohler BA, et al.: Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544-573, 2010
3. Cucino C, Buchner AM, Sonnenberg A: Continued rightward shift of colorectal cancer. Dis Colon Rectum 45:1035-1040, 2002
4. Saltzstein SL, Behling CA: Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: A study of 213,383 cases from the California Cancer Registry. J Clin Gastroenterol 41:173-177, 2007 (Pubitemid 46148659)
5. Lanza G Jr, Maestri I, Ballotta MR, et al.: Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer. Mod Pathol 7:161-165, 1994
6. Bufill JA: Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 113:779-788, 1990
7. Iacopetta B: Are there two sides to colorectal cancer? Int J Cancer 101:403-408, 2002
8. Glebov OK, Rodriguez LM, Nakahara K, et al.: Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 12:755-762, 2003 (Pubitemid 36993166)
9. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, et al.: Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54:374-384, 2005 (Pubitemid 40299094)
10. Gervaz P, Bucher P, Morel P: Two colons-two cancers: Paradigm shift and clinical implications. J Surg Oncol 88:261-266, 2004 (Pubitemid 39601269)
11. Meguid RA, Slidell MB, Wolfgang CL, et al.: Is there a difference in survival between right-versus left-sided colon cancers? Ann Surg Oncol 15:2388-2394, 2008
12. Benedix F, Kube R, Meyer F, et al.: Comparison of 17,641 patients with right- and left-sided colon cancer: Differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 53:57-64, 2010
13. Potosky AL, Riley GF, Lubitz JD, et al.: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31:732-748, 1993
14. Warren JL, Klabunde CN, Schrag D, et al.: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3-18, 2002 (suppl 8)
15. Lo NS, Sarr MG: Mucinous cystadenocarcinoma of the appendix: The controversy persists - A review. Hepatogastroenterology 50:432-437, 2003 (Pubitemid 36390538)
16. Ash AS, Ellis RP, Pope GC, et al.: Using diagnoses to describe populations and predict costs. Health Care Financ Rev 21:7-28, 2000
17. Fenton JJ, Cai Y, Green P, et al.: Trends in colorectal cancer testing among Medicare subpopulations. Am J Prev Med 35:194-202, 2008
18. Benson AB 3rd, Schrag D, Somerfield MR, et al.: American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408-3419, 2004 (Pubitemid 41103700)
19. Ribic CM, Sargent DJ, Moore MJ, et al.: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247-257, 2003 (Pubitemid 36859476)
20. Popat S, Hubner R, Houlston RS: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23:609-618, 2005 (Pubitemid 46224239)
21. Hemminki A, Mecklin JP, Järvinen H, et al.: Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 119:921-928, 2000
22. Malesci A, Laghi L, Bianchi P, et al.: Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer. Clin Cancer Res 13:3831-3839, 2007 (Pubitemid 47037588)
23. Samowitz WS, Curtin K, Ma KN, et al.: Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 10:917-923, 2001 (Pubitemid 32844897)
24. Jernvall P, Makinen MJ, Karttunen TJ, et al.: Microsatellite instability: Impact on cancer progression in proximal and distal colorectal cancers. Eur J Cancer 35:197-201, 1999 (Pubitemid 29136767)
25. Patel SA, Zenilman ME: Outcomes in older people undergoing operative intervention for colorectal cancer. J Am Geriatr Soc 49:1561-1564, 2001